Cargando…

Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder

There is mounting evidence of oncogenic hepatocyte growth factor (HGF)/Met signaling in urothelial carcinoma (UC) of the bladder. The effects of three kinase inhibitors, cabozantinib, crizotinib and EMD1214063, on HGF-driven signaling and cell growth, invasion and tumorigenicity were analyzed in cul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Young H., Apolo, Andrea B., Agarwal, Piyush K., Bottaro, Donald P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276968/ https://www.ncbi.nlm.nih.gov/pubmed/25534569 http://dx.doi.org/10.3390/cancers6042313

Ejemplares similares

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
por: McNeil, Brian K, et al.
Publicado: (2014)

Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder
por: Lee, Young H., et al.
Publicado: (2021)

Physiological Signaling and Structure of the HGF Receptor MET
por: Baldanzi, Gianluca, et al.
Publicado: (2014)

HGF/c-MET Signaling in Melanocytes and Melanoma
por: Czyz, Malgorzata
Publicado: (2018)

HGF/MET Signaling in Malignant Brain Tumors
por: Mulcahy, Elizabeth Qian Xu, et al.
Publicado: (2020)

Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer
por: Raj, Sibi, et al.
Publicado: (2022)

The role of HGF/c-MET signaling pathway in lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2016)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
por: Venepalli, Neeta K., et al.
Publicado: (2013)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012)

The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
por: Hu, Chi-Tan, et al.
Publicado: (2017)

Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion
por: Cao, Hui-Hui, et al.
Publicado: (2015)

HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling
por: Xiang, Chuan, et al.
Publicado: (2017)

Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling
por: Owusu, Benjamin Y., et al.
Publicado: (2016)

CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling
por: Yu, Jianqing, et al.
Publicado: (2021)

HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis
por: Gaudino, Giovanni, et al.
Publicado: (2014)

SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
por: De Marco, Katia, et al.
Publicado: (2023)

Rapidly Progressing Urothelial Carcinoma Due to a Rare TP53 (p.Arg110Pro) Mutation: A Case Report and Review of the Literature
por: Saoud, Ragheed, et al.
Publicado: (2021)

Epigenetic Upregulation of HGF and c-Met Drives Metastasis in Hepatocellular Carcinoma
por: Ogunwobi, Olorunseun O., et al.
Publicado: (2013)

The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid
por: Ruco, Luigi, et al.
Publicado: (2014)

HGF-MET as a breast cancer biomarker
por: Liu, Shuying
Publicado: (2015)

HGF–Met Pathway in Regeneration and Drug Discovery
por: Matsumoto, Kunio, et al.
Publicado: (2014)

HGF/Met Axis in Heart Function and Cardioprotection
por: Gallo, Simona, et al.
Publicado: (2014)

Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer
por: Della Corte, Carminia Maria, et al.
Publicado: (2014)

HGF/c-Met signaling regulates early differentiation of placental trophoblast cells
por: MA, Yeling, et al.
Publicado: (2021)

HGF/c-Met signaling promotes the migration and proliferation of deer antler MSCs
por: Wang, Miao, et al.
Publicado: (2023)

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines
por: Arriola, E, et al.
Publicado: (2011)

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma
por: Jafarnejad, Mohammad, et al.
Publicado: (2019)

Longitudinal DNA methylation changes at MET may alter HGF/c-MET signalling in adolescents at risk for depression
por: Ciuculete, Diana M., et al.
Publicado: (2019)

HGF-independent Potentiation of EGFR Action by c-Met
por: Dulak, Austin M., et al.
Publicado: (2011)

HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
por: Papaccio, Federica, et al.
Publicado: (2018)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
por: Cruickshanks, Nichola, et al.
Publicado: (2017)

Cyclic Peptide-Based Biologics Regulating HGF-MET
por: Sato, Hiroki, et al.
Publicado: (2020)

Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020)

HGF and MET: From Brain Development to Neurological Disorders
por: Desole, Claudia, et al.
Publicado: (2021)

Comprehensive molecular characterization of urothelial bladder carcinoma
Publicado: (2014)

Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022)

Sox17 Deficiency Promotes Pulmonary Arterial Hypertension via HGF/c-Met Signaling
por: Park, Chan Soon, et al.
Publicado: (2022)

Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression
por: Noriega-Guerra, Heydi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_826d9eisq5sr5npee70cl234p4